Author

Jingzi Sherman

Observed institutions: Roche (Switzerland), Roche (United States)

ORCID: 0009-0001-5569-0825

Observed ORCID: 0009-0001-5569-0825

OpenAlex ID: A5050024145

Multicenter evaluation of the Selux Next-Generation Phenotyping antimicrobial susceptibility testing system

2023 · Kristin R. Baker, Kelly Flentie, et al. · Journal of Clinical Microbiology · 13

Multi-center evaluation of the Selux next-generation phenotyping system for gram-negative direct-from-positive blood culture antimicrobial susceptibility testing

2025 · Vincent Streva, Joseph Gajewski, et al. · Journal of Clinical Microbiology · 6

Benchmarking four commercial antimicrobial susceptibility testing systems and disk diffusion to reference broth microdilution in the assessment of gram-negative bacterial isolates

2026 · Daniel D. Rhoads, Jingzi Sherman, et al. · Journal of Clinical Microbiology

The Value of Partnerships: Patient Care Isn't Something We Should Leave to Chance

2017 · Corinne R Fantz, Jingzi Sherman · The Journal of Applied Laboratory Medicine

1440: Validation of the Elecsys Brahms Procalcitonin Assay in Patients With Severe Sepsis or Septic Shock

2016 · Beverly Handy, Prentiss Jones, et al. · Critical Care Medicine

Multicenter Evaluation of Current Total 25-OH Vitamin D Assays: A Comparison of the Roche Elecsys Protein Binding Assay and Four Immunoassays With a NIST-Standardized LC-MS/MS Method

2014 · Marvin Lessig, Alicia Algeciras-Schimnich, et al. · American Journal of Clinical Pathology

Works count: 6

Citation count: 19

H-index: 2

I10-index: 1